Orville G Kolterman Selected Research

Weight Gain

4/2002

A randomized study and open-label extension evaluating the long-term efficacy of pramlintide as an adjunct to insulin therapy in type 1 diabetes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Orville G Kolterman Research Topics

Disease

6	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 05/2013 - 04/2002
6	Type 2 Diabetes Mellitus (MODY) 01/2005 - 01/2002
4	Nausea 05/2013 - 01/2002
3	Body Weight (Weight, Body) 05/2013 - 01/2002
3	Hypoglycemia (Reactive Hypoglycemia) 03/2003 - 01/2002
2	Weight Loss (Weight Reduction) 04/2004 - 03/2003
1	Overweight 04/2004
1	Weight Gain 04/2002
1	Anorexia 04/2002

Drug/Important Bio-Agent (IBA)

10	pramlintide (Symlin)FDA Link 05/2013 - 01/2002
8	Insulin (Novolin)FDA Link 05/2013 - 01/2002
6	Islet Amyloid PolypeptideIBA 01/2004 - 01/2002
5	Glucose (Dextrose)FDA LinkGeneric 01/2004 - 01/2003
2	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 05/2013 - 04/2004
2	Exenatide (Byetta)FDA Link 01/2005 - 07/2003
2	Insulin Lispro (Humalog)FDA Link 01/2004 - 11/2003
2	Short-Acting InsulinIBA 01/2004 - 11/2003
2	Hormones (Hormone)IBA 01/2003 - 01/2002
1	Blood Glucose (Blood Sugar)IBA 05/2013
1	Hemoglobins (Hemoglobin)IBA 04/2004
1	Hypoglycemic Agents (Hypoglycemics)IBA 07/2003
1	Metformin (Glucophage)FDA LinkGeneric 03/2003
1	Glucagon (Glukagon)FDA Link 01/2003
1	Triglycerides (Triacylglycerol)IBA 01/2003

Therapy/Procedure

7	Therapeutics 05/2013 - 01/2002
4	Injections 04/2005 - 04/2002
2	Glycemic Control 05/2013 - 04/2002
1	Subcutaneous Injections 03/2003